ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1622

Genome-Wide Association Analysis and Whole Genome Sequencing Identify Variants Associated with Radiographic Severity of Rheumatoid Arthritis in African Americans

Vincent A. Laufer1, Richard J. Reynolds2, Maria I. Danila3, R. Curtis Hendrickson4, Elliot J. Lefkowitz5, Devin Absher6, Robert P. Kimberly7 and S. Louis Bridges Jr.8, 1Division of Clinical Rheumatology and Immunology, University of Alabama at Birmingham, Birmingham, AL, 2Medicine, University of Alabama at Birmingham, Birmingham, AL, 3AL, 4University of Alabama at Birmingham, Birmingham, AL, 5Microbiology, University of Alabama at Birmingham, Birmingham, AL, 6Hudson Alpha Institute for Biotechnology, Huntsville, AL, 7Medicine, Clinical Immun & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 8Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: GWAS, Immunogenetics, pathogenesis and rheumatoid arthritis, radiography, rheumatoid arthritis, synovium

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Joint damage manifested by bony erosions and joint space narrowing is a major contributor to the morbidity and mortality of RA. Reports in Caucasians (EA) indicate that as much as 58% of radiographic severity of RA may be heritable, but little is known about the heritability of this phenotype, especially in African Americans (AA).

Methods: 175 AA RA patients with longstanding ACPA-positive RA that never progressed to radiographic damage, and 264 autoantibody-positive AA RA patients with radiographic joint damage were genotyped using Illumina Omni 1M and 1S arrays. Whole genome sequence (WGS) data (Complete Genomics) was obtained on a subset of 62 autoantibody-positive AA RA patients (31 with radiographic damage, 31 without damage). DMARD/biologic use, disease duration, sex, smoking status, and the top 10 principal components were included as covariates. We sought variants associated with radiographic damage using a genome-wide significance threshold of p <10-8. Using our WGS data, we analyzed 126 loci for association with damage: 101 loci associated with susceptibility in EA and 25 loci previously reported to be associated with radiographic severity of RA among EA. We conducted covariate-controlled gene based testing (α = 4*10-4) on these loci using SKAT-O and then conducted immune cell enhancer burden tests (α = 1.6*10-5) in these regions.

Results: We did not detect any associations of SNP variants with damage at a genome wide level of significance with Illumina 1M/1S data; the most strongly associated variant with radiographic damage was rs4743949 (chr9:92722181, p = 5.76*10-7, OR= 0.60) located in an enhancer region nearest mir4290, a non-coding RNA, and about 800kB 5’ of Syk. Gene burden testing of WGS data revealed loci having an enrichment of variants that have previously associated with radiographic severity of RA. 3 of the 25 gene burden tests showed evidence of association; these were ILF3 (1.31*10-4, gene based burden test), ATG5 (7.27*10-7, T-cell enhancer region), and CXCR5 (p=1.28*10-5, B-cell enhancer region). We did not detect association of radiographic severity with the HLA-DRB1 locus in either single variant or burden testing.

Conclusion: Consistent with recent reports, variation in enhancer regions, many of which are T-cell enhancers, were associated with damage. For example, the enhancer region of ATG5, a gene important for T and B cell lymphocyte development and required for appropriate processing of antigens for presentation by MHC class II, was significantly associated. The HLA region was not found to be associated with RA severity in this study, possibly because the whole cohort is ACPA positive. Appropriate parsing of NGS data may elucidate associated loci that are missed using array-based GWA studies.


Disclosure: V. A. Laufer, None; R. J. Reynolds, K01 NIH Research Grant, 2; M. I. Danila, None; R. C. Hendrickson, None; E. J. Lefkowitz, None; D. Absher, None; R. P. Kimberly, None; S. L. Bridges Jr., None.

To cite this abstract in AMA style:

Laufer VA, Reynolds RJ, Danila MI, Hendrickson RC, Lefkowitz EJ, Absher D, Kimberly RP, Bridges SL Jr.. Genome-Wide Association Analysis and Whole Genome Sequencing Identify Variants Associated with Radiographic Severity of Rheumatoid Arthritis in African Americans [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/genome-wide-association-analysis-and-whole-genome-sequencing-identify-variants-associated-with-radiographic-severity-of-rheumatoid-arthritis-in-african-americans/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genome-wide-association-analysis-and-whole-genome-sequencing-identify-variants-associated-with-radiographic-severity-of-rheumatoid-arthritis-in-african-americans/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology